BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32504193)

  • 21. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological profiles in subgroups of patients with Sjögren's syndrome.
    Manoussakis MN; Tzioufas AG; Pange PJ; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():89-92. PubMed ID: 3473654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoassay Detects Salivary Anti-SSA/Ro-52 Autoantibodies in Seronegative Patients with Primary Sjögren's Syndrome.
    Kamounah S; Tayob N; Chiang S; Wei F; Park JK; Kwon HM; Feng Z; Chia D; Pedersen AML; Song YW; Wong DTW
    Immunohorizons; 2023 Jul; 7(7):554-561. PubMed ID: 37466644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.
    Cafaro G; Perricone C; Baldini C; Quartuccio L; Priori R; Carubbi F; Ferro F; Colafrancesco S; Bini V; De Vita S; Giacomelli R; Gerli R; Bartoloni E;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):53-56. PubMed ID: 33095137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren's syndrome.
    Mossel E; Delli K; van Nimwegen JF; Stel AJ; Kroese FGM; Spijkervet FKL; Vissink A; Arends S; Bootsma H;
    Ann Rheum Dis; 2017 Nov; 76(11):1883-1889. PubMed ID: 28754802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of immunological features with clinical manifestations in primary Sjogren's syndrome: a single-center cross-sectional study.
    Relangi HSK; Naidu GSRSNK; Sharma V; Kumar M; Dhir V; Sharma SK; Sharma A; Minz RW; Jain S
    Clin Exp Med; 2022 Nov; 22(4):613-620. PubMed ID: 34762228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
    Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
    Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren's syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria.
    Locht H; Pelck R; Manthorpe R
    Autoimmun Rev; 2005 Jun; 4(5):276-81. PubMed ID: 15990074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impression Cytology and
    Hao R; Liu Z; Chou Y; Wang Y; Ren X; Jiang X; Li X
    Front Immunol; 2022; 13():829320. PubMed ID: 35585979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of diagnosis and disease course in primary Sjögren's syndrome: Results from datamining of electronic health records.
    Sandhya P; Janardana R; Sudarsanam T; Mahasampath G; Prakash JAJ; Danda D
    Int J Rheum Dis; 2019 Sep; 22(9):1768-1774. PubMed ID: 31328441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome.
    Seeliger T; Prenzler NK; Gingele S; Seeliger B; Körner S; Thiele T; Bönig L; Sühs KW; Witte T; Stangel M; Skripuletz T
    Front Immunol; 2019; 10():1600. PubMed ID: 31354737
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
    Abbara S; Seror R; Henry J; Chretien P; Gleizes A; Hacein-Bey-Abina S; Mariette X; Nocturne G
    RMD Open; 2019; 5(2):e001033. PubMed ID: 31673417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome in a Korean cohort.
    Lee J; Koh JH; Kim JW; Sung YK; Lee SS; Choe JY; Shim SC; Kim HS; Kim HR; Kim JM; Kwon SR; Kim HO; Shin K; Lee CH; Chung SH; Kwok SK; Ju JH; Park SH
    Rheumatol Int; 2018 Sep; 38(9):1651-1660. PubMed ID: 30030624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between ocular and extra-ocular assessment in primary Sjögren's syndrome.
    Da Cunha E; Mariette X; Desmoulins F; Bergé E; Nocturne G; Benmalek A; Haigh O; Seror R; Labetoulle M; Rousseau A
    Joint Bone Spine; 2022 Oct; 89(5):105426. PubMed ID: 35716880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features.
    Kabasakal Y; Kitapçıoğlu G; Karabulut G; Tezcan M; Balkarlı A; Aksoy A; Yavuz Ş; Yılmaz S; Kaşifoğlu T; Kalyoncu U; Dalkılıç E; Tufan A; Mercan R; Yıldız F; Şentürk T; Önen F; Bes C; Erken E; Tunç E; Kamalı S; Tarhan E; Yazıcı A; Düzgün N; Bıçakçıgil M; Yılmaz S; Özmen M; Öcal L; Alibaz-Öner F; Solmaz D; Çobankara V; Nalbant S; Kasapoğlu Günal E; Kaşkari D; Göker B
    Rheumatol Int; 2017 May; 37(5):675-684. PubMed ID: 28289872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations between clinical parameters of dry eye disease and serologic profiles in Sjögren's syndrome.
    Lee Y; Jeon HS; Hyon JY
    Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):2925-2932. PubMed ID: 35460362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria.
    Ramos-Casals M; Brito-Zerón P; Perez-De-Lis M; Jimenez I; Blanco MJ; Bove A; Soto MJ; Akasbi M; Diaz C; Sentís J; Siso A
    Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):178-85. PubMed ID: 19578996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).
    Brito-Zerón P; Acar-Denizli N; Ng WF; Zeher M; Rasmussen A; Mandl T; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnström M; Praprotnik S; Sène D; Bartoloni E; Solans R; Rischmueller M; Suzuki Y; Isenberg DA; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura T; Giacomelli R; Devauchelle-Pensec V; Knopf A; Bombardieri M; Trevisani VF; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenveider C; Horvath IF; Sivils KL; Olsson P; De Vita S; Sánchez-Guerrero J; Kilic L; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):102-112. PubMed ID: 30156539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.